The Ca2+-dependent cell adhesion molecule E-cadherin functions in the establishment and maintenance of epithelial cell morphology during embryogenesis and adulthood. Downregulation or complete shut-down of E-cadherin expression and mutation of the gene are observed during the progression of tumors of epithelial origin (carcinomas) and correlate with the metastatic potential. We have introduced a targeted mutation into the E-cadherin gene by homologous recombination in mouse embryonic stem cells. The mutation removes E-cadherin sequences essential for Ca2+ binding and for adhesive function. These embryonic stem cells were used to generate mice carrying the mutation. Heterozygous mutant animals appear normal and are fertile. However, the homozygous mutation is not compatible with life: E-cadherin -/-embryos show severe abnormalities before implantation. Particularly, the adhesive cells of the morula dissociate shortly after compaction has occurred, and their morphological polarization is then destroyed. Interestingly, the blastomers are still able to form desmosomes and tight junctions at sites of distorted cell-cell contact. Thus, maternal E-cadherin suffices for initial compaction of the morula but not for further preimplantation development to occur. Cellular adherence in developing and adult tissues is mediated by cell adhesion molecules, of which one class, the cadherins, functions in a Ca2+-dependent manner (1). E-cadherin, one member of this family, is responsible for the cell adhesion of epithelial cells and also plays an essential role in generation and maintenance of epithelial cell polarity (2, 3). E-cadherin is located in the adherens junctions, which are specialized regions on the lateral side of the epithelial plasma membrane.
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The extracellular domain of E-cadherin binds Ca2+ and Ecadherin expressed on neighboring cells (1, 4) . The cytoplasmic domain interacts with a group of proteins, the catenins, that mediate the contact with the microfilament network through unknown linkage molecules. a-Catenin has structural similarities with vinculin, which is located at the membrane attachment sites of microfilaments in fibroblasts; ,B-catenin is similar to amardillo ofDrosophila; and -y-catenin is identical or closely related to plakoglobin found also at the desmosomes (5) (6) (7) .
Epithelial differentiation and polarization occur early in ontogeny, when in the morula stage, the embryo compacts and each cell polarizes along its apicobasal axis to generate an epithelial-like phenotype (8) . E-cadherin plays an important role in the adhesion of the blastomers, since functionally interfering anti-E-cadherin antibodies cause the early embryo to decompact (9, 10) . Programing of the embryo for compaction requires previous protein synthesis. Also E-cadherin is synthesized and is present in the membrane before compaction of the morula commences. However, it is then distributed in a nonpolar manner and is nonadhesive (10, 11) . The exact mechanism that renders E-cadherin functional is not known, but phosphorylation of E-cadherin has been implicated in the regulation (11) .
Controlled loss of epithelial adhesion and polarity that causes mesenchymal cell morphology can occur in development, for example, during mesoderm formation. A similar but uncontrolled epithelial-mesenchymal conversion is observed in malignant tumors of epithelial origin. Malignant carcinoma cells are characterized in general by poor intercellular adhesion, loss of the differentiated epithelial morphology, and increased cellular motility. Downregulation or a complete shut-down of E-cadherin expression, mutation of the Ecadherin gene, or other mechanisms that interfere with the integrity of the adherens junctions are observed in carcinoma cells (2, 12, 13) . In human tumors, the loss of E-cadherinmediated cell adhesion correlates with the loss of the epithelial morphology and with the acquisition of metastatic potential by the carcinoma cells (14) .
To study the role of E-cadherin genetically, we have altered functionally important gene sequences by homologous recombination in embryonal stem (ES) cells, and these modified ES cells were used to generate mice that carry the mutation. In the homozygous state, the mutation affects preimplantation development severely. A normal morphology of the mutant embryos up to and including the compaction stage of the morula is observed; consequently, the adhesive cells dissociate and appear morphologically nonpolar. Interestingly, desmosomes and tight junctions are found in the distorted embryos. The availability of mice carrying the E-cadherin mutation in a heterozygous state will allow the genetic analysis of the role of epithelial cell adhesion in tumor progression. to introduce the E-cadherin targeting vector by electroporation. Targeted ES cell clones were enriched by selection with G418 (400 ,ug/ml) and gancyclovir (2 ,uM) and identified by PCR. Southern blot analysis on the ES cell clones with three probes [a probe corresponding to cDNA sequences outside of the targeting vector (pA), a probe corresponding to cDNA sequences present on the targeting vector (pC), and sequences of the neo-resistance gene (pB) (see Fig. 1 )] was used to verify that a single integration event had occurred by homologous I I recombination. Blastocyst injections and identification of chimeras that transmit the E-cadherin mutation were performed essentially as described (18) . Routinely, the genotype of animals and embryos was identified by PCR with primer combinations CCTCTCCTTTGACAGGAACCTCCGT (complementary to the intron 6-exon 7 junction) and CGAATTCGC-CAATGACAAGACGCTGG (complementary to promoter sequences of the neo-resistance gene) or Analysis of Early Embryos. Heterozygous animals were mated and the morning past coitum was assigned as day 0.5 of development. On day 1.5 of development, the embryos were isolated by flushing the infundibulum. Further development of the embryos was observed in vitro by incubation in M16 medium for 48-96 h in a humidified C02/air chamber (19) . Where indicated, the zona pellucida of the embryos was removed by incubation with acid Tyrode's solution (19) .
MATERIALS AND METHODS
Immunohistochemistry and Electron Microscopy. Embryos were fixed in 4% (vol/vol) formaldehyde, stained with a rat anti-mouse E-cadherin IgG (DECMA-1, Sigma) and a Cy3-coupled goat anti-rat IgG (Dianova, Hamburg), and viewed with a confocal laser scanning microscope (Lasersharp MRC 500, Bio-Rad) or a Zeiss Axiophot fluorescence microscope. For sectioning, the embryos were positioned in small droplets of agarose, fixed in 2.5% (vol/vol) glutaraldehyde, and postfixed in 1% OSO4. After staining with tannic acid and uranyl acetate, the tissue was dehydrated and embedded in Epon 812.
Semithin sections (0.5 gm) were stained with methylene blue and examined by light microscopy; thin sections (0.1 gm) were contrasted with lead citrate and examined by electron microscopy.
RESULTS
Generation of ES Cells and Mice with a Mutant E-Cadherin Gene. The targeting vector for the E-cadherin gene was constructed with 129/J genomic DNA and contained the neo-resistance gene and the Herpes simplex virus thymidine kinase gene as positive and negative selection markers, respectively (16) . To introduce a null mutation, sequences of exon 7 and 8 of E-cadherin were removed (Fig. 1) ; the deleted fragment includes DNA encoding a Ca2+-binding site reported (20) to be essential for E-cadherin function. The targeting vector was introduced by electroporation into the E14-1 ES cells (17) . Cells that had introduced the DNA by homologous recombination were enriched by selection with G418 and gancyclovir and identified by PCR; nine positive clones were found in the 250 colonies analyzed. Selected colonies were subcloned and their genomic DNA was analyzed by Southern blot hybridization to verify that a single integration event had occurred by homologous recombination (Fig. 1) .
Mutant ES cells derived from three subclones were injected into blastocysts of C57BL/6 animals. Germ-line chimeras were obtained from blastocysts injected with one subclone. The chimeras were used to produce animals heterozygous for the mutation that appeared normal and were fertile. However, among the offspring from matings of heterozygous animals, no viable homozygous mutant animals were found, indicating that such a genotype is not compatible with normal development. Since early development is disturbed by anti-E-cadherin antibodies (9, 10), we next analyzed preimplantation development.
Early Development of E-Cadherin -I-Embryos. Embryos were isolated at the two-or four-cell stage, transferred into M16 medium, and incubated to observe early development in vitro. After the observation was completed, the individual embryos were genotyped by PCR (Fig. lc) 36 h of in vitro culture (c, f), analyzed by immunofluorescence microscopy, are shown; note that to achieve visability of the maternal E-cadherin, the photograph shown in c was exposed five times longer than the photograph shown in f. (Bars = 25 ,Lm.) that was excluded from blastomers, whereas pretreatment with sodium' azide allowed trypan blue to enter (Fig. 3 a and d) .
Therefore, decompaction of the embryos is not the result of unspecific cell death. The -/ -embryos never formed blastocysts with a proper blastocoel; instead, loose cell aggregates were observed (at 72-96 h of incubation in vitro; Fig. 2 d'-f ) . In contrast, all wild-type (+/ +) or heterozygous mutant (+/-) embryos formed normal blastocysts containing a blastocoel (at 48-72 h of incubation in vitro). The blastocysts consequently expanded; the majority ruptured the zona pellucida and emerged from the zona in the hatching process, whereas the remaining embryos collapsed after expansion (at 72-96 h of incubation in vitro; Fig. 2 d-f) . In total, we analyzed Genetics: Riethmacher et al. Maternal E-Cadherin Functions in the Compaction of the Morula. Antibodies against E-cadherin have been reported to decompact embryos at the morula stage, indicating that Ecadherin functions in the Ca2+-dependent adhesion and polarization of early morula cells (9, 10) . Nevertheless, our embryos carrying a homozygous mutation in the E-cadherin gene are initially able to compact but do not sustain the compacted state. We studied -/-embryos in the presence of anti-E-cadherin antibodies (DECMA-1) to determine whether morula compaction occurred. Interestingly, such antibodies inhibited the compaction of -/-embryos. Immunohistological analysis of E-cadherin -/-embryos demonstrated the presence of residual E-cadherin protein, albeit only up to the morula stage (Fig. 3c) . After the morphological distortion was apparent (at 60 h of incubation in vitro), E-cadherin protein could not be observed by immunohistochemistry (Fig. 3b) . Thus, the functional E-cadherin protein present during the initial compaction of -/-embryos is probably derived from maternal sources (see ref. 11 ).
Morphological Appearance of Cell Contact Sites in Mutant Embryos. Electron microscopy was used to observe the cell contact sites of the distorted embryos; these were found to be severely altered in morphology. The membranes of opposing inner and outer blastomers formed an irregular interdigitating pattern (Fig. 4) . These interdigitating membranes are typical for -/ -embryos and no comparable structures are present in embryos with normal external morphology (+/+ and +/-embryos). Interestingly, in distorted embryos, we found desmosomes in cell contact sites of both inner and outer blastomers and tight junctions at the cell contact sites between outer blastomers (Fig. 4) .
DISCUSSION
We have introduced a mutation into the mouse E-cadherin gene by homologous recombination in ES cells; the mutant ES cells were used to produce mice carrying the mutation. Since functionally essential coding sequences were removed in the E-cadherin gene (see ref. 20) and termination codons in all three reading frames were introduced, no mRNA encoding adhesive E-cadherin protein can be produced in homozygous mutant cells. Animals that carry one copy of this mutant E-cadherin gene appear healthy and are fertile. However, matings between such animals do not produce homozygous mutant offspring, demonstrating the essential function of E-cadherin for normal development.
E-Cadherin Is Essential for Cell Polarity in the Early Mouse Embryo. Embryos that are homozygous for the Ecadherin mutation develop normally up to the morula stage and compact properly. The morula cells become initially adherent and polarize. However, the polarized state of the cells cannot be sustained, and consequently, the embryos appear severely distorted. Mutant (-/-) embryos do not form normal blastocysts and hatching from the zona pellucida is never observed. Since hatching is a prerequisite for implantation of the embryos, further development cannot proceed in vivo.
It has been shown (9, 10) that functionally interfering antibodies against E-cadherin decompact the morula. This indicates that the early cell polarization during compaction of the morula is dependent on E-cadherin. Nevertheless, embryos homozygous for the E-cadherin mutation are initially able to compact and their cells are able to polarize. Anti-Ecadherin antibodies inhibit this initial compaction, demonstrating that E-cadherin function is not compensated by other cell adhesion molecules. It has been established (11) (14) . In many instances, downregulation is controlled at the transcriptional level (23) . In diffuse-type gastric carcinomas, mutations in the E-cadherin gene are observed in 50% of the cases. In addition, the second intact allele is often lost in such tumor cells (12) . Mutation and loss of the intact second copy are typical for genes that play a causative role in the development and progression of tumors (24) . Other mechanisms that interfere with the integrity of the adherens junction, for instance, mutation of a-catenin, have been reported to occur in tumor cells as well (13) . In 
